Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2021-01-28 Report Publication Anno…
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Terminarz publikacji raportów okresowych BIOTON S.A. w roku 2021 - Content (PL)
Report Publication Announcement Classification · 98% confidence The document explicitly outlines the schedule for the company's periodic reports (quarterly, semi-annual, and annual reports) for the year 2021, including specific dates for release. It references Polish Ministry of Finance regulations regarding periodic information disclosure. This document is not the report itself (like 10-K or IR), but rather an announcement detailing *when* those reports will be published. This fits the definition of a Report Publication Announcement (RPA), which signals the timing of future report releases.
2021-01-28 Polish
raport rewidenta ds. szczególnych
Legal Proceedings Report Classification · 99% confidence The document is titled "Raport rewidenta do spraw szczególnych" (Special Auditor's Report) and explicitly states it was prepared in accordance with a court order ('Postanowienie Sądu') regarding specific matters concerning the company Bioton S.A., including the sale of its subsidiary SciGen Ltd. The content details the scope of the examination, sources of information used by the auditor (Grant Thornton Polska), and the methodology. This structure and content strongly indicate a formal, specialized audit or review report mandated by a legal or regulatory body, rather than a standard annual report (10-K), quarterly report (IR), or a simple announcement (RPA/RNS). Among the provided definitions, 'Audit Report / Information' (AR) is the most fitting category for a standalone, specialized audit report, even if it's not a standard financial statement audit.
2020-11-03 Polish
Raport rewidenta ds. szczególnych - Content (PL)
Legal Proceedings Report Classification · 99% confidence The document is very short (745 characters) and explicitly states that the Management Board ('Zarząd') is forwarding ('przekazuje') a report from an appointed auditor ('rewidenta ds. szczególnych' / 'Biegły') concerning a specific shareholder resolution matter from a past Extraordinary General Meeting (EGM). This structure—announcing the availability of a specific, non-standard report (an auditor's special investigation report) rather than containing the full report content—strongly suggests it is an announcement about a report's publication. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a specific, non-standard regulatory announcement that isn't a standard financial report (10-K, IR, ER) or a standard meeting material (AGM-R, DEF 14A). It is not a standard Audit Report (AR) as it is an announcement of a special auditor's report related to a shareholder dispute, not the full annual audit.
2020-11-03 Polish
Powołanie Prezesa Zarządu - Content (PL)
Board/Management Information Classification · 100% confidence The document text explicitly states that the Supervisory Board of BIOTON S.A. appointed Mr. Jeremy Launders as the President of the Management Board (CEO) on October 30, 2020. The content details his professional background, experience, and confirms no conflicts of interest. This directly relates to changes in senior management personnel. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short (2063 chars), but it is the announcement/details of the change itself, not an announcement *about* a future announcement, so RPA/RNS is not the primary fit.
2020-10-30 Polish
Rezygnacja Prezesa Zarządu - Content (PL)
Board/Management Information Classification · 99% confidence The document text is very short (219 characters) and announces the immediate resignation of Mr. Robert Neymann from the position of CEO ('Prezesa Zarządu') of the company, citing personal reasons. This directly relates to a change in senior management. Based on the definitions, this aligns perfectly with the Board/Management Information category.
2020-10-30 Polish
informacja dodatkowa Q3 2020
Interim / Quarterly Report Classification · 100% confidence The document is a detailed quarterly financial report ('RAPORT KWARTALNY') for the third quarter of 2020 for the BIOTON S.A. Group. It contains comprehensive financial statements, segment reporting, geographical revenue breakdowns, and management's discussion of accounting principles and business performance. It is not an announcement of a report, but the report itself, containing substantive financial data. 9M 2020
2020-10-30 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.